The FDA has approved these medications for adults with obesity or those who are overweight and have at least one related health condition, such as high blood pressure or type 2 diabetes
For example, the tirzepatide 15 mg group lost 11.2 kg, versus the semaglutide group, who lost 5.7 kg
In a trial of semaglutide, people who switched to a placebo regained around 7% of their body weight over the following year, while those who kept taking the medication lost a further 8%
Pain: vulvar discomfort, dyspareunia, pelvic floor symptoms Regulatory evidence: No labelled vulvovaginal pain terms in Ozempic adverse reaction tables
They list milligram doses without explaining how those milligrams translate to syringe units at your specific vial concentration
You administer this medication subcutaneously once a week in various sites like the abdomen, thigh, or upper arm